Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective of this study is to evaluate the efficacy and safety of copanlisib in patients with indolent or aggressive Non-Hodgkin’s Lymphoma (NHL) who have progressed after standard therapy. The objective of study part B is to evaluate the efficacy and safety of copanlisib in patients with indolent B-cell NHL relapsed after, or refractory to widely used approved therapies in standard practice.
Inclusion criteria
- Patients with relapsed, indolent or aggressive Non- Hodgkin’s lymphomas or patients with indolent B-cell Non-Hodgkin's lymphoma relapsed after or refractory to standard therapy